01
Define the clinical finding
Diagnosis and a limited clinical aim precede device choice.
Device-Based Treatments · Physician-Led Assessment · Istanbul
Device-Based Treatments
Laser, light, radiofrequency and ultrasound are energy classes, not ready-made treatment protocols. The exact system, route, target tissue, labelled use and clinical aim must be identified before suitability is discussed.
Different devices sold under similar names are not assumed equivalent. No online page can choose settings, depth, applicator, treatment line or session number.
Physician-Led Orientation
Four levels before method selection
A reasoned sequence begins with the clinical question.
Online review can organise the question. Final suitability follows from in-person examination, the exact product or device and an individual risk–benefit assessment.
02
Identify the system
The exact device, energy source, applicator and consumables are verified.
03
Map tissue and risk
Invasiveness, target depth, skin type and vulnerable anatomy shape suitability.
04
Plan evidence and exit
Device-specific evidence, alternatives, follow-up and stopping criteria are agreed.
Device-Based Treatments · 01–03
Needle, laser and ultrasound routes remain distinct
Invasive path, optical columns and focused sound require different safety maps.
RF microneedling, fractional lasers and focused ultrasound differ in energy, route, target tissue and labelled context.
01Device-specific route
RF Microneedling
RF microneedling explained by needle system, radiofrequency delivery, device label, target tissue, evidence, risks, alternatives and stopping criteria.
Decision boundaryMicroneedling and RF indications are device-, body-area- and region-specific; clearance of one system does not authorise another use.
Open RF Microneedling02Device-specific route
Fractional Laser Treatment
Fractional laser treatment with ablative and non-ablative systems separated by wavelength, chromophore, tissue effect, recovery and safety.
Decision boundaryLabelled indications and body areas are product- and jurisdiction-specific; wavelength alone does not establish authorisation.
Open Fractional Laser Treatment03Device-specific route
Microfocused Ultrasound / HIFU
Microfocused ultrasound and HIFU separated by device, imaging, transducer, focal depth, labelled use, tissue target, evidence and neurological risks.
Decision boundaryMicrofocused ultrasound, systems with visualisation and broad HIFU marketing terms are not automatically equivalent; labelled uses differ by product and region.
Open Microfocused Ultrasound / HIFUDevice-Based Treatments · 04–06
Light targets require diagnosis and chromophore logic
IPL, pigment laser and vascular laser are not interchangeable.
Broad-spectrum filtered light and wavelength-specific lasers retain separate target, skin-type and eye-safety decisions.
01Device-specific route
IPL Treatment
IPL explained as filtered broad-spectrum non-laser light with device, filter, pulse, chromophore, skin type, evidence and ocular safety boundaries.
Decision boundaryAuthorised indications, filters, body sites and operators vary by exact IPL product and region.
Open IPL Treatment02Device-specific route
Pigment Laser
Pigment laser treatment with diagnosis and malignancy exclusion before wavelength, pigment depth, skin type, evidence, risks and alternatives.
Decision boundaryA device label does not authorise treatment of every brown lesion; regional indication and lesion type must match.
Open Pigment Laser03Device-specific route
Vascular Laser
Vascular laser assessment by vessel diagnosis, diameter, depth, anatomy, wavelength, cooling, evidence, risks and alternatives.
Decision boundaryClearance or marking applies to a named product, indication and region; a wavelength alone is not a treatment authorisation.
Open Vascular LaserDevice-Based Treatments · 07–09
Current path, fibre path and low-level light stay separate
Radiofrequency, interstitial laser and PBM/LED have different invasiveness and aims.
A shared marketing promise cannot merge unlike energy delivery, tissue exposure or evidence.
01Device-specific route
Radiofrequency Skin Tightening
Radiofrequency skin tightening separated by electrode arrangement, energy path, invasiveness, tissue target, thermal control, evidence and implant risks.
Decision boundaryThe exact system's labelled indication, tissue, anatomical site and regional status must be verified; RF is not one device class clinically.
Open Radiofrequency Skin Tightening02Device-specific route
Interstitial Fibre Laser
Interstitial fibre laser separated from surface laser and surgery by fibre path, invasiveness, target tissue, licence, evidence, complications and alternatives.
Decision boundaryThe exact device, fibre, intended tissue, access route and regional authorisation must be verified; marketing names do not establish a licensed indication.
Open Interstitial Fibre Laser03Existing EN-I5 route
Photobiomodulation / LED
Existing canonical page for wavelength-, irradiance-, dose- and device-specific light assessment.
Decision boundaryLinked once; no duplicate page or canonical is created.
Open Photobiomodulation / LEDQuality and Safety Framework
Four binding principles
Premium care means clearer selection, boundaries and follow-up.
Advertising language and package logic are replaced by product traceability, anatomy, proportionate alternatives and documented review.
01
Diagnosis before energy
A device name never substitutes for examination.
02
Identity before equivalence
Similar marketing names do not make systems interchangeable.
03
Anatomy before settings
Energy path and vulnerable structures define the safety boundary.
04
Review before repetition
Expected reactions, complications and the endpoint are assessed before another procedure.
Bağdat Caddesi · Istanbul
International patient pathway
Travel, examination and follow-up form one medical process.
The in-person appointment remains the decision point. Product records, early safety, return travel and local medical access are considered before treatment.
- 01Before travel
Organise the question
History and photographs prepare discussion without selecting a device.
- 02In Istanbul
Examine in person
Diagnosis, anatomy, exact system, label and alternatives are reviewed.
- 03Treatment day
Keep traceability
Device, consumable, region and observations remain recorded.
- 04After return
Arrange escalation
Stop criteria and local medical access are agreed before departure.
The Doctor Aslan Approach
Medical decision before machine selection
The device follows the tissue question.
Doctor Aslan keeps system identity, energy path, anatomy, label, evidence and alternatives in the same decision.
Separate technologies
Laser, IPL, RF, ultrasound and LED retain different mechanisms.
Verify the system
Manufacturer, model, applicator and intended use remain traceable.
Plan for harm
Thermal, optical, neurological, pigment and invasive risks have an escalation route.
Accept no treatment
Withholding a device remains a valid medical decision.
Medical responsibility: Dr İsmail AslanMedical review: 24 August 2026General patient information; no personal device selection, settings or outcome guarantee
Frequently Asked Questions
Short and clear
Questions commonly asked before a decision.
These answers provide general orientation and do not replace personal diagnosis or treatment planning.
01What is Device-Based Treatments?+
Device-Based Treatments is described on this page as one defined clinical route. Its role, limits and possible alternatives are considered together rather than treating the method name as a personal recommendation.
02Who may be assessed for Device-Based Treatments?+
Suitability depends on the medical question, history, examination, the exact product or device where relevant, realistic aims and an individual benefit–risk assessment.
03What remains undecided after an online review?+
Diagnosis, definitive suitability, the treatment protocol, product, dose or device settings, expected response and the option not to proceed remain subject to personal medical assessment.
04How are treatment and follow-up in Istanbul planned?+
The in-person examination remains the decision point. Expected early reactions, warning signs, the direct contact route, return travel and access to appropriate local medical care are discussed before treatment.
Next Step
Define the finding · identify the device · compare alternatives